Discover how UnitedHealthcare covers Jardiance 25mg, an effective medication for managing type 2 diabetes and reducing cardiovascular risks. Learn about coverage options under Medicare, enrollment steps, and plan details for affordable medication access.

UnitedHealthcare Coverage for Jardiance 25mg

Jardiance 25mg (empagliflozin) is an oral medication used to help control blood sugar levels in people with type 2 diabetes. It also reduces the risk of cardiovascular events like heart attacks and strokes. Empagliflozin works by helping the kidneys eliminate excess glucose from the blood, supporting effective blood sugar management.

Individuals with type 1 diabetes, severe kidney issues, or on dialysis should avoid Jardiance 25mg. Common side effects include urinary tract infections, dehydration, dizziness, increased heart rate, genital infections, blood in urine, headaches, and fatigue.

For best results, Jardiance 25mg should be combined with a balanced diet and regular physical activity. The standard dose is 10mg in the morning, which can be increased to 25mg if tolerated.

The FDA has approved Jardiance following rigorous clinical trials involving over 4,500 type 2 diabetes patients, verifying its safety and effectiveness.

Medicare typically covers about 67% of Jardiance 25mg costs through Part D and Medicare Advantage plans. Coverage does not include Medicare Parts A and B, which do not cover prescriptions.

You can select a Medicare Advantage plan with drug benefits or sign up for a standalone Medicare Part D plan. UnitedHealthcare offers various prescription drug plans for Jardiance 25mg to help lower medication expenses.

Enroll easily online at UnitedHealthcare's website to view plan premiums, copays, deductibles, pharmacy networks, and options. Plans range from budget-friendly, broad-network options to comprehensive prescription coverage.